Advertisement
Screener

Nektar Therapeutics (NKTR) Auditor

Nektar Therapeutics Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-13: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2025-03-14: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2024-03-05: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2023-02-28: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-132025-12-31Ernst & Young LLP42San Mateo, CaliforniaNo
2025-03-142024-12-31Ernst & Young LLP42San Mateo, CaliforniaNo
2024-03-052023-12-31Ernst & Young LLP42San Mateo, CaliforniaYes
2023-02-282022-12-31Ernst & Young LLP42San Mateo, CaliforniaYes
2022-03-012021-12-31Ernst & Young LLP42Redwood City, CaliforniaYes
2021-02-262020-12-31Ernst & Young LLPRedwood City, CaliforniaYes
2020-02-282019-12-31Ernst & Young LLPRedwood City, California
2019-03-012018-12-31Ernst & Young LLPRedwood City, California
2018-03-012017-12-31Ernst & Young LLPRedwood City, California
2017-03-012016-12-31Ernst & Young LLPRedwood City, California
2015-02-262014-12-31ERNST & YOUNG LLPRedwood City, California
2014-02-272013-12-31ERNST & YOUNG LLPRedwood City, California
2013-03-012012-12-31ERNST & YOUNG LLPRedwood City, California
2012-02-292011-12-31ERNST & YOUNG LLPRedwood City, California
2011-03-012010-12-31Young LLPPalo Alto, California
2009-03-062008-12-31ERNST & YOUNG LLPSan Jose, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Generate Biomedicines, Inc. (GENB)United States$2.052B
Biohaven Ltd. (BHVN)United States$1.990B-3.83
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89